Pharma channel feed

Thou­sands of gene and cell ther­a­pies are in­un­dat­ing FDA re­view­ers as the agency tries to keep up

3 years ago
Cell/Gene Tx
FDA+

Brent Saun­ders to lead Bausch + Lomb in re­turn to CEO slot

3 years ago
People

In a first, CMS will test pay­ing less for drugs cleared via ac­cel­er­at­ed ap­proval

3 years ago
FDA+

No­vavax to pro­vide 1.5M more Covid vac­cine dos­es to the US gov­ern­ment

3 years ago
Coronavirus
Manufacturing

A bio­man­u­fac­tur­ing site is com­ing to Cana­da’s Prince Ed­ward Is­land

3 years ago
Manufacturing

Time to go? Urovant em­pha­sizes qual­i­ty-of-life con­cerns in first Gemte­sa TV ad

3 years ago
Marketing

Mar­ket­ingRx roundup: Su­per Bowl re­play on phar­ma ads plus a spoof; Pfiz­er asks ‘Got Boost­er?’ again with new celeb

3 years ago
Marketing

Should Nar­can spray be sold over the counter? FDA pos­es po­ten­tial pack­ag­ing changes

3 years ago
FDA+

US gov­ern­ment, Pfiz­er and oth­ers side with Sanofi and Re­gen­eron in Supreme Court patent case

3 years ago
Law

Sun Phar­ma is­sues re­call for more than 34,000 bot­tles of blood pres­sure med­ica­tion

3 years ago
FDA+
Manufacturing

Gilead­'s Kite clues pa­tients in with con­ver­sa­tion­al CAR-T cell ther­a­py cam­paign

3 years ago
Marketing

FDA re­jects Bio­con and Vi­a­tris' Avastin biosim­i­lar af­ter in­spec­tion ques­tion marks

3 years ago
FDA+

Up­dat­ed: Sor­ren­to files for Chap­ter 11 af­ter los­ing ar­bi­tra­tion to Patrick Soon-Sh­iong biotech

3 years ago

Bris­tol My­ers, 2sev­en­ty roll out full Abec­ma da­ta in ear­li­er-stage can­cer

3 years ago
R&D

Genen­tech to start con­struc­tion on a new man­u­fac­tur­ing fa­cil­i­ty in Cal­i­for­nia

3 years ago
Manufacturing

Eli Lil­ly faces an­oth­er age dis­crim­i­na­tion law­suit

3 years ago
Law

Pub­li­cis Health Me­dia pres­i­dent An­drea Palmer looks back at 10 years of phar­ma me­dia — and me­te­oric changes

3 years ago
Marketing

Vi­sion mat­ters: Bausch + Lomb asks mac­u­lar de­gen­er­a­tion pa­tients to share the sights that in­spire them

3 years ago
Marketing

Japan can­cels 140M dose or­der for No­vavax Covid vac­cine amid 'low­er than ex­pect­ed' de­mand

3 years ago
FDA+

In­fla­tion re­bates: CMS lays the ground rules for phar­ma com­pli­ance

3 years ago
Law

As­traZeneca CEO Pas­cal So­ri­ot aims for 15 new drug launch­es by 2030

3 years ago

Sen­ate Ju­di­cia­ry Com­mit­tee sends five phar­ma-re­lat­ed bills to the floor

3 years ago

Ab­b­Vie talks next steps as first Hu­mi­ra com­peti­tor makes it to mar­ket

3 years ago

Mid­night in­ter­net search­es? En­do’s new dis­ease aware­ness cam­paign echoes re­al pa­tient con­cerns

3 years ago
Marketing
First page Previous page 145146147148149150151 Next page Last page
A service from the Financial Times